Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO.

Since the publication of the 2004 update to the American Association of Physicists in Medicine (AAPM) Task Group No. 43 Report (TG-43U1) and its 2007 supplement (TG-43U1S1), several new low-energy photon-emitting brachytherapy sources have become available. Many of these sources have satisfied the AAPM prerequisites for routine clinical purposes and are posted on the Brachytherapy Source Registry managed jointly by the AAPM and the Imaging and Radiation Oncology Core Houston Quality Assurance Center (IROC Houston). Given increasingly closer interactions among physicists in North America and Europe, the AAPM and the Groupe Européen de Curiethérapie-European Society for Radiotherapy & Oncology (GEC-ESTRO) have prepared another supplement containing recommended brachytherapy dosimetry parameters for eleven low-energy photon-emitting brachytherapy sources. The current report presents consensus datasets approved by the AAPM and GEC-ESTRO. The following sources are included: 125 I sources (BEBIG model I25.S17, BEBIG model I25.S17plus, BEBIG model I25.S18, Elekta model 130.002, Oncura model 9011, and Theragenics model AgX100); 103 Pd sources (CivaTech Oncology model CS10, IBt model 1031L, IBt model 1032P, and IsoAid model IAPd-103A); and 131 Cs (IsoRay Medical model CS-1 Rev2). Observations are included on the behavior of these dosimetry parameters as a function of radionuclide. Recommendations are presented on the selection of dosimetry parameters, such as from societal reports issuing consensus datasets (e.g., TG-43U1, AAPM Report #229), the joint AAPM/IROC Houston Registry, the GEC-ESTRO website, the Carleton University website, and those included in software releases from vendors of treatment planning systems. Aspects such as timeliness, maintenance, and rigor of these resources are discussed. Links to reference data are provided for radionuclides (radiation spectra and half-lives) and dose scoring materials (compositions and mass densities). The recent literature is examined on photon energy response corrections for thermoluminescent dosimetry of low-energy photon-emitting brachytherapy sources. Depending upon the dosimetry parameters currently used by individual physicists, use of these recommended consensus datasets may result in changes to patient dose calculations. These changes must be carefully evaluated and reviewed with the radiation oncologist prior to their implementation.

[1]  D. Rogers,et al.  An EGSnrc investigation of the PTP correction factor for ion chambers in kilovoltage x rays. , 2006, Medical physics.

[2]  W. Butler,et al.  Erratum: Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations (Medical Physics (2004) 31 (633-674)) , 2004 .

[3]  M. Rivard.  Monte Carlo radiation dose simulations and dosimetric comparison of the model 6711 and 9011 125I brachytherapy sources. , 2009, Medical physics.

[4]  Bruce G. Terrell,et al.  National Oceanic and Atmospheric Administration , 2020, Federal Regulatory Guide.

[5]  J. Williamson,et al.  Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. , 2012, Medical physics.

[6]  Lellery Storm,et al.  Photon cross sections from 1 keV to 100 MeV for elements Z=1 to Z=100 , 1970 .

[7]  A. Meigooni,et al.  Dosimetric characteristics of the InterSource103 palladium brachytherapy source. , 2000, Medical physics.

[8]  Y S Horowitz,et al.  Highlights and pitfalls of 20 years of application of computerised glow curve analysis to thermoluminescence research and dosimetry. , 2013, Radiation protection dosimetry.

[9]  Experimental and Monte Carlo dosimetric characterization of a 1 cm (103)Pd brachytherapy source. , 2014, Brachytherapy.

[10]  C. Steyaert,et al.  Atmosphere , 2018, The Creativity Complex.

[11]  L A DeWerd,et al.  Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source. , 2010, Medical physics.

[12]  Determination of the TG-43 dosimetry parameters and isodose curves of 103 Pd source model OptiSeed TM in soft tissue phantom , 2011 .

[13]  J. H. Hubbell,et al.  Tables of X-Ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients 1 keV to 20 MeV for Elements Z = 1 to 92 and 48 Additional Substances of Dosimetric Interest , 1995 .

[14]  P. Scalliet,et al.  An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect. , 2008, Medical physics.

[15]  P. Basran,et al.  CT, MR, and ultrasound image artifacts from prostate brachytherapy seed implants: the impact of seed size. , 2012, Medical physics.

[16]  Marinus A Moerland,et al.  Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  K. Shortt,et al.  The response of lif thermoluminescence dosemeters to photon beams in the energy range from 30 kV x rays to 60Co gamma rays. , 2003, Radiation protection dosimetry.

[18]  Anders Ahnesjö,et al.  Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation. , 2005, Medical physics.

[19]  P. Bownes,et al.  Evaluation of the visibility of a new thinner ¹²⁵I radioactive source for permanent prostate brachytherapy. , 2012, Brachytherapy.

[20]  C. Lodwick.  Clinical Dosimetry Measurements in Radiotherapy , 2011 .

[21]  Zuofeng Li,et al.  Monte Carlo and experimental dosimetry of an I125 brachytherapy seed. , 2006, Medical physics.

[22]  Jose Perez-Calatayud,et al.  Influence of photon energy spectra from brachytherapy sources on Monte Carlo simulations of kerma and dose rates in water and air. , 2010, Medical physics.

[23]  M. Rivard.  Brachytherapy dosimetry parameters calculated for a Cs131 source: Brachytherapy dosimetry parameters calculated for a Cs131 source , 2007 .

[24]  D. Kocher.  Nuclear Data Sheets for A = 103 , 1974 .

[25]  J. H. Hubbell,et al.  Atomic form factors, incoherent scattering functions, and photon scattering cross sections , 1975 .

[26]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[27]  M. Rivard.  Brachytherapy dosimetry parameters calculated for a 131Cs source. , 2007, Medical physics.

[28]  M. Rivard,et al.  COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs. , 2008, Medical physics.

[29]  L. Dewerd,et al.  The effect of ambient pressure on well chamber response: experimental results with empirical correction factors. , 2005, Medical physics.

[30]  Jose Perez-Calatayud,et al.  Dependence with air density of the response of the PTW SourceCheck ionization chamber for low energy brachytherapy sources. , 2013, Medical physics.

[31]  D. Baltas,et al.  Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed. , 2002, Medical physics.

[32]  D. Baltas,et al.  Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed. , 2005, Medical physics.

[33]  M. Rivard.  Erratum: “Brachytherapy dosimetry parameters calculated for a Cs131 source” [Med. Phys.34, 754–762 (2007)] , 2008 .

[34]  S. Chiu‐Tsao,et al.  Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[35]  G. Ibbott,et al.  Thermoluminescence dosimetry measurements of brachytherapy sources in liquid water. , 2008, Medical physics.

[36]  R. Taylor,et al.  EGSnrc Monte Carlo calculated dosimetry parameters for Ir192 and Yb169 brachytherapy sources. , 2008, Medical physics.

[37]  Ravinder Nath,et al.  Erratum: “Supplement to the 2004 update of the AAPM Task Group No. 43 Report” [Med. Phys. 34, 2187–2205 (2007)] , 2010 .

[38]  K. Sowards.  Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE P103d brachytherapy source , 2007, Journal of applied clinical medical physics.

[39]  J. Williamson,et al.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2003, Medical physics.

[40]  R. W. Roussin,et al.  Description of the DLC-99/HUGO package of photon interaction data in ENDF/B-V format , 1983 .

[41]  C. Soares,et al.  Influence of phantom materials on the energy dependence of LiF:Mg,Ti thermoluminescent dosimeters exposed to 20–300 kV narrow x-ray spectra, 137Cs and 60Co photons , 2014, Physics in medicine and biology.

[42]  Dimos Baltas,et al.  New 125I brachytherapy source IsoSeed I25.S17plus: Monte Carlo dosimetry simulation and comparison to sources of similar design , 2013, Journal of contemporary brachytherapy.

[43]  G. Ibbott,et al.  Dosimetric characterization of a 131Cs brachytherapy source by thermoluminescence dosimetry in liquid water. , 2008, Medical physics.

[44]  D. Rogers,et al.  On determining dose rate constants spectroscopically. , 2012, Medical physics.

[45]  Larry A DeWerd,et al.  A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO. , 2011, Medical physics.

[46]  J. H. Scofield,et al.  Theoretical photoionization cross sections from 1 to 1500 keV. , 1973 .

[47]  L. Dewerd,et al.  Determination of the intrinsic energy dependence of LiF:Mg,Ti thermoluminescent dosimeters for 125I and 103Pd brachytherapy sources relative to 60Co. , 2014, Medical physics.

[48]  Zhe Chen,et al.  Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant. , 2007, Medical physics.

[49]  F. Brown.  Status of Cross-section Data Libraries for MCNP , 2013 .

[50]  D. Baltas,et al.  On the dose rate constant of the selectSeed 125I interstitial brachytherapy seed. , 2006, Medical physics.

[51]  P. Scalliet,et al.  Dosimetric study of a new palladium seed. , 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[52]  W. J. Bair,et al.  Diagnostic Ultrasound Safety A summary of the technical report “ Exposure Criteria for Medical Diagnostic Ultrasound : II . Criteria Based on all Known Mechanisms ” issued by the National Council on Radiation Protection and Measurements , 2015 .

[53]  M. Plamondon,et al.  Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy. , 2014, Medical physics.

[54]  D. Baltas,et al.  Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed. , 2001, Medical physics.

[55]  R. Taylor,et al.  An EGSnrc Monte Carlo-calculated database of TG-43 parameters. , 2008, Medical physics.

[56]  Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source. , 2005, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[57]  Larry A DeWerd,et al.  The effect of ambient pressure on well chamber response: Monte Carlo calculated results for the HDR 1000 plus. , 2005, Medical physics.

[58]  S. Seltzer,et al.  Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy. , 2004, Medical physics.

[59]  Gabor Fichtinger,et al.  AAPM and GEC-ESTRO guidelines for image-guided robotic brachytherapy: report of Task Group 192. , 2014, Medical physics.

[60]  José Pérez-Calatayud,et al.  Dosimetric prerequisites for routine clinical use of photon emitting brachytherapy sources with average energy higher than 50 kev. , 2007, Medical physics.

[61]  G. A. Carlsson,et al.  Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV). , 2011, Medical physics.

[62]  Y. Horowitz.  Update on AAPM Task Group No. 43 report--brachytherapy and TLD. , 2009, Radiation protection dosimetry.

[63]  D. W. O. Rogersb,et al.  EGSnrc Monte Carlo calculated dosimetry parameters for 192 Ir and 169 Yb brachytherapy sources , 2008 .

[64]  Dermott E. Cullen,et al.  Tables and graphs of photon-interaction cross sections from 0. 1 keV to 100 MeV derived from the LLL Evaluated-Nuclear-Data Library , 1978 .

[65]  D. Rogers,et al.  Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds. , 2014, Medical physics.

[66]  Z. Chen,et al.  Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry. , 2005, Medical physics.

[67]  Zhe Chen,et al.  Photon spectrometry for the determination of the dose-rate constant of low-energy photon-emitting brachytherapy sources. , 2007, Medical physics.

[68]  R Nath,et al.  Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources. Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee. Ad Hoc Subcommittee of the Radiation Therapy Committee. , 1998, Medical physics.

[69]  M. Mcewen,et al.  An experimental and computational investigation of the standard temperature-pressure correction factor for ion chambers in kilovoltage x rays. , 2007, Medical physics.

[70]  G. Ibbott,et al.  Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model. , 2012, Brachytherapy.

[71]  D W O Rogers,et al.  EGSnrc Monte Carlo calculated dosimetry parameters for 192Ir and 169Yb brachytherapy sources. , 2008, Medical physics.

[72]  J. F. Briesmeister.  MCNP-A General Monte Carlo N-Particle Transport Code , 1993 .

[73]  A. Meigooni,et al.  Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[74]  Å. Carlsson Tedgren,et al.  Determination of absorbed dose to water around a clinical HDR (192)Ir source using LiF:Mg,Ti TLDs demonstrates an LET dependence of detector response. , 2012, Medical physics.

[75]  D. Thwaites,et al.  Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET. , 2013, Medical physics.

[76]  Septimiu Salcudean,et al.  Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants. , 2012, Medical physics.

[77]  D. Cullen,et al.  Tables and graphs of photon interaction cross sections from 1.0 keV to 100 MeV derived from the LLL Evaluated Nuclear Data Library , 1975 .

[78]  S. Chiu‐Tsao,et al.  A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant. , 2010, Brachytherapy.

[79]  R. Taylor,et al.  Benchmarking brachydose: Voxel based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters. , 2007, Medical physics.

[80]  Jose Perez-Calatayud,et al.  Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO. , 2012, Medical physics.

[81]  Lujie Chen,et al.  58 , 2016, Tao te Ching.

[82]  Zhe Chen,et al.  Experimental characterization of the dosimetric properties of a newly designed I-Seed model AgX100 ¹²⁵I interstitial brachytherapy source. , 2012, Brachytherapy.

[83]  A convolution algorithm for brachytherapy dose computations in heterogeneous geometries. , 1991, Medical physics.

[84]  M Saiful Huq,et al.  Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine. , 2004, Medical physics.

[85]  J. H. Hubbell,et al.  Relativistic atomic form factors and photon coherent scattering cross sections , 1979 .

[86]  R. Taylor,et al.  An EGSnrc Monte Carlo-calculated database of TG-43 parameters. , 2008, Medical physics.

[87]  P. Greer,et al.  Evaluation of an a-Si EPID in direct detection configuration as a water-equivalent dosimeter for transit dosimetry. , 2010, Medical physics.

[88]  E. Storm,et al.  PHOTON CROSS SECTIONS FROM 0.001 TO 100 MeV FOR ELEMENTS 1 THROUGH 100. , 1967 .

[89]  Monte Carlo and thermoluminescence dosimetry of the new IsoSeed® model I25.S17 I125 interstitial brachytherapy seed. , 2005, Medical physics.

[90]  D. Baltas,et al.  Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source. , 2014, Brachytherapy.

[91]  J F Williamson,et al.  Monte Carlo evaluation of kerma at a point for photon transport problems. , 1987, Medical physics.

[92]  P. Scalliet,et al.  Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays. , 2010, Medical physics.

[93]  Kirsten Boedeker,et al.  An analysis of MCNP cross-sections and tally methods for low-energy photon emitters. , 2002, Physics in medicine and biology.

[94]  S. Rudin.  A Handbook of Radioactivity Measurements Procedures , 1979 .

[95]  D. Fisher,et al.  Multiple-estimate monte carlo calculation of the dose rate constant for a cesium-131 interstitial brachytherapy seed. , 2006, Medical physics.

[96]  P. Olko.  Microdosimetric Interpretation of Thermoluminescence Efficiency of LiF:Mg,Cu,P (MCP-N) Detectors for Weakly and Densely Ionising Radiations , 1996 .

[97]  Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation. , 2008, Medical physics.

[98]  Mark J. Rivard,et al.  A technical evaluation of the Nucletron FIRST system: Conformance of a remote afterloading brachytherapy seed implantation system to manufacturer specifications and AAPM Task Group report recommendations , 2005, Journal of applied clinical medical physics.

[99]  L. T. Dillman.  Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. , 1969, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[100]  W. Butler,et al.  Supplement to the 2004 update of the AAPM Task Group No. 43 Report. , 2007, Medical physics.

[101]  S. Vynckier,et al.  Dosimetric study of a new polymer encapsulated palladium-103 seed. , 2005, Physics in medicine and biology.

[102]  L A DeWerd,et al.  LiF:Mg,Ti TLD response as a function of photon energy for moderately filtered x-ray spectra in the range of 20-250 kVp relative to 60Co. , 2008, Medical physics.

[103]  103Pd strings: Monte Carlo assessment of a new approach to brachytherapy source design. , 2014, Medical physics.